References
1. Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020;48(2):155-63. https://doi.org/10.1007/s15010-020-01401-y.
2. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 1. Geneva: World Health Organization; 2020. p. 1-5.
3. World Health Organization. Listings of WHO’s response to COVID-19. (2020). https://www.who.int/news/item/29-06-2020-covidtimeline. Accessed 03-04-2023.
4. World Health Organization. Pneumonia of unknown cause – China. (2020). https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON229. Accessed 03-04-2023.
5. Allam Z. The first 50 days of COVID-19: A detailed chronological timeline and extensive review of literature documenting the pandemic. 2020. p. 1-7.
6. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5.
7. Centers for Disease Control and Prevention. CDC Museum COVID-19 Timeline. (2020). https://www.cdc.gov/museum/timeline/covid19.html. Accessed 03-04-2023.
8. World Health Organization. WHO Statement regarding cluster of pneumonia cases in Wuhan, China,. (2020). https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china. Accessed.
9. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3). https://doi.org/10.2807/1560-7917.Es.2020.25.3.2000045.
10. Corman V, Bleicker T, Brünink S, et al. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR. Berlin 2020. p. 12.
11. Pan American Health Organization, World Health Organization. Epidemiological Alert: Novel coronavirus (nCoV) - 16 January 2020. 2020. p. 1-6.
12. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 3. Geneva: World Health Organization; 2020. p. 1-7.
13. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. 2020;382(10):929-36. https://doi.org/10.1056/NEJMoa2001191.
14. World Health Organization. Mission summary: WHO Field Visit to Wuhan, China 20-21 January 2020. (2020). https://www.who.int/china/news/detail/22-01-2020-field-visit-wuhan-china-jan-2020. Accessed 03-04-2023.
15. Zhou T, Nguyen TT, Zhong J, Liu J. A COVID-19 descriptive study of life after lockdown in Wuhan, China. R Soc Open Sci. 2020;7(9):200705. https://doi.org/10.1098/rsos.200705.
16. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 4. Geneva: World Health Organization; 2020. p. 1-7.
17. World Health Organization. Statement on the first meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). (2020). https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Accessed 03-04-2023.
18. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 5. Geneva: World Health Organization; 2020. p. 1-7.
19. Bernard Stoecklin S, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25(6). https://doi.org/10.2807/1560-7917.Es.2020.25.6.2000094.
20. World Health Organization. WHO R&D Blueprint: Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection. Geneva2020. p. 1-16.
21. Pan American Health Organization, World Health Organization. PAHO Director urges readiness to detect cases of new coronavirus in the Americas. (2020). https://www.paho.org/en/news/27-1-2020-paho-director-urges-readiness-detect-cases-new-coronavirus-americas. Accessed.
22. Ministers: Department of Health and Aged Care. First confirmed case of novel coronavirus in Australia. (2020). https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/first-confirmed-case-of-novel-coronavirus-in-australia. Accessed 03-04-2023.
23. World Health Organization. 2019-nCoV outbreak: first cases confirmed in Europe. (2020). https://www.who.int/europe/news/item/25-01-2019-2019-ncov-outbreak-first-cases-confirmed-in-europe. Accessed 06-04-2023.
24. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 7. Geneva: World Health Organization; 2020. p. 1-5.
25. World Health Organization. Readiness is the key to detect, combat spread of the new coronavirus. (2020). https://www.who.int/southeastasia/news/detail/27-01-2020-readiness-is-the-key-to-detect-combat-spread-of-the-new-coronavirus. Accessed 06-04-2023.
26. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 8. Geneva: World Health Organization; 2020. p. 1-7.
27. Isabel S, Graña-Miraglia L, Gutierrez JM, et al. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. Scientific Reports. 2020;10(1):14031. https://doi.org/10.1038/s41598-020-70827-z.
28. Phan T. Genetic diversity and evolution of SARS-CoV-2. Infection, Genetics and Evolution. 2020;81:104260. https://doi.org/https://doi.org/10.1016/j.meegid.2020.104260.
29. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 9. Geneva: World Health Organization; 2020. p. 1-6.
30. Trump Whitehouse - National Archives. Statement from the Press Secretary Regarding the President’s Coronavirus Task Force. (2020). https://trumpwhitehouse.archives.gov/briefings-statements/statement-press-secretary-regarding-presidents-coronavirus-task-force/. Accessed 06-04-2023.
31. The Peter Doherty Institute for Infection and Immunity (Doherty Institute). Doherty Institute scientists first to grow and share 2019 novel coronavirus. (2020). https://www.doherty.edu.au/news-events/news/coronavirus. Accessed 06-04-2023.
32. World Health Organization Regional Office for the Eastern Mediterranean. WHO confirms first cases of novel coronavirus (2019-nCoV) in the Eastern Mediterranean Region. (2020). https://www.emro.who.int/media/news/who-confirms-first-cases-of-novel-coronavirus-2019-ncov-in-the-eastern-mediterranean-region.html. Accessed 06-04-2023.
33. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 10. Geneva: World Health Organization; 2020. p. 1-7.
34. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 11. Geneva: World Health Organization; 2020. p. 1-8.
35. World Health Organization African Region. WHO ramps up preparedness for novel coronavirus in the African region. (2020). https://www.afro.who.int/news/who-ramps-preparedness-novel-coronavirus-african-region. Accessed 06-04-2023.
36. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 12. Geneva: World Health Organization; 2020. p. 1-7.
37. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 13. Geneva: World Health Organization; 2020. p. 1-7.
38. World Health Organization. 2019 Novel Coronavirus (2019-nCoV): Strategic preparedness and response plan. Geneva 2020. p. 1-28.
39. U.S. Food and Drug Administration. FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic. (2020). https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first. Accessed 06-04-2023.
40. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 18. Geneva: World Health Organization; 2020. p. 1-6.
41. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 20. Geneva: World Health Organization; 2020. p. 1-7.
42. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 22. Geneva: World Health Organization; 2020. p. 1-7.
43. United Nations. Highlights of the Noon Briefing by Stephane Dujarric, Spokesman for Secretary-General António Guterres. (2020). https://www.un.org/sg/en/content/highlight/2020-02-11.html. Accessed 06-04-2023.
44. World Health Organization. Novel Coronavirus (2019-nCoV): situation report, 21. Geneva: World Health Organization; 2020. p. 1-6.
45. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 29. Geneva: World Health Organization; 2020. p. 1-7.
46. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 26. Geneva: World Health Organization; 2020. p. 1-6.
47. World Health Organization. Munich Security Conference. (2020). https://www.who.int/director-general/speeches/detail/munich-security-conference. Accessed 06-04-2023.
48. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 30. Geneva: World Health Organization; 2020. p. 1-8.
49. Food and Agriculture Organization of the United Nations (FAOLEX Database). Decree-Law 23 February 2020, n. 6 Urgent measures regarding containment and emergency management of the epidemiological emergency from COVID-19. (2020). https://www.fao.org/faolex/results/details/en/c/LEX-FAOC194202. Accessed 06-04-2023.
50. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 36. Geneva: World Health Organization; 2020. p. 1-6.
51. World Health Organization. Joint WHO and ECDC mission in Italy to support COVID-19 control and prevention efforts,. (2020). https://www.who.int/europe/news/item/24-02-2020-joint-who-and-ecdc-mission-in-italy-to-support-covid-19-control-and-prevention-efforts. Accessed 06-04-2023.
52. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 37. Geneva: World Health Organization; 2020. p. 1-6.
53. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 39. Geneva: World Health Organization; 2020. p. 1-7.
54. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 40. Geneva: World Health Organization; 2020. p. 1-7.
55. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 2020. p. 1-40.
56. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics. Accessed 06-04-2023.
57. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 41. Geneva: World Health Organization; 2020. p. 1-7.
58. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 42. Geneva: World Health Organization; 2020. p. 1-7.
59. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA and CDC take action to increase access to respirators, including N95s, for health care personnel. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-and-cdc-take-action-increase-access-respirators-including-n95s. Accessed 06-04-2023.
60. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 47. Geneva: World Health Organization; 2020. p. 1-8.
61. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 51. Geneva: World Health Organization; 2020. p. 1-9.
62. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 52. Geneva: World Health Organization; 2020. p. 1-9.
63. World Health Organization Regional Office for the Eastern Mediterranean. WHO and public health experts conclude COVID-19 mission to Islamic Republic of Iran. (2020). https://www.emro.who.int/iran/news/delegation-of-who-and-public-health-experts-concludes-covid-19-mission-to-iran.html. Accessed 06-04-2023.
64. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 54. Geneva: World Health Organization; 2020. p. 1-9.
65. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 13 March 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19---13-march-2020. Accessed 06-04-2023.
66. Trump Whitehouse - National Archives. Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak. (2020). https://trumpwhitehouse.archives.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/. Accessed 06-04-2023.
67. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 55. Geneva: World Health Organization; 2020. p. 1-9.
68. World Health Organization Regional Office for the Eastern Mediterranean. WHO technical mission visits Iraq to step up COVID-19 detection and response activities. (2020). https://www.emro.who.int/iraq/news/who-technical-mission-visits-iraq-for-covid-19-response.html. Accessed 06-04-2023.
69. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 56. Geneva: World Health Organization; 2020. p. 1-9.
70. National Institutes of Health. NIH clinical trial of investigational vaccine for COVID-19 begins. (2020). https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins. Accessed 06-04-2023.
71. University of Minnesota. COVID-19 Clinical Trial Launches at University of Minnesota. (2020). https://med.umn.edu/news/covid-19-clinical-trial-launches-university-minnesota. Accessed 06-04-2023.
72. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 60. Geneva: World Health Organization; 2020. p. 1-9.
73. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 18 March 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---18-march-2020. Accessed 06-04-2023.
74. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 59. Geneva: World Health Organization; 2020. p. 1-11.
75. U.S. Food and Drug Administration. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. (2020). https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19#:~:text=%5B3%2F19%2F2020%5D,disease%20(COVID%2D19). Accessed 06-04-2023.
76. NSW Government (NSW Health). Cruise ship passengers identified with COVID-19. (2020). https://www.health.nsw.gov.au/news/Pages/20200320_03.aspx. Accessed 06-04-2023.
77. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic. Accessed 06-04-2023.
78. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 63. Geneva: World Health Organization; 2020. p. 1-10.
79. U.S. Food and Drug Administration. FDA and EMA Collaborate to Facilitate SARS-CoV-2 Vaccine Development. (2020). https://www.fda.gov/news-events/fda-voices/fda-and-ema-collaborate-facilitate-sars-cov-2-vaccine-development. Accessed 06-04-2023.
80. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 25 March 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---25-march-2020. Accessed 06-04-2023.
81. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup, March 24, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-march-24-2020. Accessed 06-04-2023.
82. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 66. Geneva: World Health Organization; 2020. p. 1-11.
83. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 67. Geneva: World Health Organization; 2020. p. 1-12.
84. World Health Organization Regional Office for the Eastern Mediterranean. WHO delegation concludes COVID-19 technical mission to Egypt. (2020). https://www.emro.who.int/media/news/who-delegation-concludes-covid-19-technical-mission-to-egypt.html. Accessed 06-04-2023.
85. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 27 March 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---27-march-2020. Accessed 06-04-2023.
86. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA takes action to help increase U.S. supply of ventilators and respirators for protection of health care workers, patients. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-action-help-increase-us-supply-ventilators-and-respirators. Accessed 06-04-2023.
87. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 68. Geneva: World Health Organization; 2020. p. 1-10.
88. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup March 30, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-march-30-2020. Accessed 06-04-2023.
89. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 71. Geneva: World Health Organization; 2020. p. 1-11.
90. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup March 31, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-march-31-2020. Accessed 06-04-2023.
91. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 73. Geneva: World Health Organization; 2020. p. 1-13.
92. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 75. Geneva: World Health Organization; 2020. p. 1-11.
93. The Peter Doherty Institute for Infection and Immunity (Doherty Institute). Possible coronavirus drug identified by Melbourne scientists. (2020). https://www.doherty.edu.au/news-events/news/possible-coronavirus-drug-identified-by-melbourne-scientists. Accessed 06-04-2023.
94. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Blood Purification Device to Treat COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19. Accessed 06-04-2023.
95. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 77. Geneva: World Health Organization; 2020. p. 1-11.
96. World Health O. Advice on the use of masks in the context of COVID-19: interim guidance, 6 April 2020. Geneva: World Health Organization; 2020.
97. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 79. Geneva: World Health Organization; 2020. p. 1-13.
98. World Health Organization. WHO lists two COVID-19 tests for emergency use. (2020). https://www.who.int/news-room/detail/07-04-2020-who-lists-two-covid-19-tests-for-emergency-use. Accessed 06-04-2023.
99. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 83. Geneva: World Health Organization; 2020. p. 1-11.
100. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 85. Geneva: World Health Organization; 2020. p. 1-12.
101. World Health Organization. Public statement for collaboration on COVID-19 vaccine development. (2020). https://www.who.int/news/item/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development. Accessed 06-04-2023.
102. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 84. Geneva: World Health Organization; 2020. p. 1-11.
103. Trump Whitehouse - National Archives. Remarks by President Trump in Press Briefing. (2020). https://trumpwhitehouse.archives.gov/briefings-statements/remarks-president-trump-press-briefing-072220/. Accessed 06-04-2023.
104. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 86. Geneva: World Health Organization; 2020. p. 1-13.
105. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 88. Geneva: World Health Organization; 2020. p. 1-12.
106. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 89. Geneva: World Health Organization; 2020. p. 1-13.
107. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 91. Geneva: World Health Organization; 2020. p. 1-14.
108. World Health Organization. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. (2020). https://www.who.int/news-room/commentaries/detail/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19. Accessed 06-04-2023.
109. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 92. Geneva: World Health Organization; 2020. p. 1-12.
110. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-test-patient-home-sample-collection. Accessed 06-04-2023.
111. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 94. Geneva: World Health Organization; 2020. p. 1-12.
112. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 96. Geneva: World Health Organization; 2020. p. 1-11.
113. World Health Organization. WHO Director-General's opening remarks at the launch of the Access to COVID-19 Tools Accelerator. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-launch-of-the-access-to-covid-19-tools-accelerator. Accessed 06-04-2023.
114. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 97. Geneva: World Health Organization; 2020. p. 1-11.
115. Toubiana J, Cohen JF, Brice J, et al. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France. J Clin Immunol. 2021;41(3):526-35. https://doi.org/10.1007/s10875-020-00941-0.
116. Paediatric Intensive Care Society. PICS Statement: Increased number of reported cases of novel presentation of multisystem inflammatory disease. 2020. p. 1-2.
117. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 99. Geneva: World Health Organization; 2020. p. 1-12.
118. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 100. Geneva: World Health Organization; 2020. p. 1-12.
119. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 101. Geneva: World Health Organization; 2020. p. 1-12.
120. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup April 30, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-30-2020. Accessed 06-04-2023.
121. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 102. Geneva: World Health Organization; 2020. p. 1-16.
122. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment. Accessed 06-04-2023.
123. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 106. Geneva: World Health Organization; 2020. p. 1-17.
124. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 4 May 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---4-may-2020. Accessed 06-04-2023.
125. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 108. Geneva: World Health Organization; 2020. p. 1-17.
126. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 6 May 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---6-may-2020. Accessed 06-04-2023.
127. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 111. Geneva: World Health Organization; 2020. p. 1-16.
128. World Health Organization. COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. (2020). https://www.who.int/news-room/commentaries/detail/covid-19-and-the-use-of-angiotensin-converting-enzyme-inhibitors-and-receptor-blockers. Accessed 06-04-2023.
129. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup May 8, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-8-2020. Accessed 06-04-2023.
130. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-antigen-test-help-rapid-detection-virus-causes. Accessed 06-04-2023.
131. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 113. Geneva: World Health Organization; 2020. p. 1-17.
132. World Health Organization. WHO statement: Tobacco use and COVID-19. (2020). https://www.who.int/news-room/detail/11-05-2020-who-statement-tobacco-use-and-covid-19. Accessed 06-04-2023.
133. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 May 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-may-2020. Accessed 06-04-2023.
134. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 117. Geneva: World Health Organization; 2020. p. 1-15.
135. Shulkin D. What Health Care Can Learn from Operation Warp Speed. NEJM Catalyst. 2021:1-6. https://doi.org/10.1056/CAT.21.0001.
136. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-standalone-home-sample-collection-kit-can-be-used. Accessed 06-04-2023.
137. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 119. Geneva: World Health Organization; 2020. p. 1-15.
138. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 122. Geneva: World Health Organization; 2020. p. 1-17.
139. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 124. Geneva: World Health Organization; 2020. p. 1-17.
140. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 127. Geneva: World Health Organization; 2020. p. 1-17.
141. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 25 May 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---25-may-2020. Accessed 06-04-2023.
142. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 129. Geneva: World Health Organization; 2020. p. 1-17.
143. World Health O. Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: World Health Organization; 2020.
144. World Health Organization. WHO Foundation Established to Support Critical Global Health Needs. (2020). https://www.who.int/news/item/27-05-2020-who-foundation-established-to-support-critical-global-health-needs. Accessed 06-04-2023.
145. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 132. Geneva: World Health Organization; 2020. p. 1-16.
146. World Health Organization. International community rallies to support open research and science to fight COVID-19. (2020). https://www.who.int/news-room/detail/29-05-2020-international-community-rallies-to-support-open-research-and-science-to-fight-covid-19. Accessed 06-04-2023.
147. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 133. Geneva: World Health Organization; 2020. p. 1-18.
148. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 135. Geneva: World Health Organization; 2020. p. 1-18.
149. Ledford H, Noorden RV. High-profile coronavirus retractions raise concerns about data oversight. Nature 2020;582(160):1. https://doi.org/https://doi.org/10.1038/d41586-020-01695-w.
150. World Health Organization. WHO welcomes crucial new funding for vaccines. (2020). https://www.who.int/news-room/detail/04-06-2020-who-welcomes-crucial-new-funding-for-vaccines. Accessed 06-04-2023.
151. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 137. Geneva: World Health Organization; 2020. p. 1-17.
152. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 5 June 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---5-june-2020. Accessed 06-04-2023.
153. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 140. Geneva: World Health Organization; 2020. p. 1-17.
154. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 141. Geneva: World Health Organization; 2020. p. 1-15.
155. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup June 10, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-june-10-2020. Accessed 06-04-2023.
156. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 145. Geneva: World Health Organization; 2020. p. 1-16.
157. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and. Accessed 06-04-2023.
158. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: Daily Roundup June 15, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-june-15-2020. Accessed 06-04-2023.
159. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 15 June 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---15-june-2020. Accessed 06-04-2023.
160. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 149. Geneva: World Health Organization; 2020. p. 1-18.
161. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 151. Geneva: World Health Organization; 2020. p. 1-17.
162. World Health Organization. Breastfeeding and COVID-19. (2020). https://www.who.int/news-room/commentaries/detail/breastfeeding-and-covid-19. Accessed 06-04-2023.
163. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 156. Geneva: World Health Organization; 2020. p. 1-17.
164. CNBC. CanSino’s coronavirus vaccine candidate approved for military use in China. (2020). https://www.cnbc.com/2020/06/29/cansinos-coronavirus-vaccine-candidate-approved-for-military-use-in-china.html. Accessed 06-04-2023.
165. Gavi The Vaccine Alliance. The COVID-19 vaccine race. (2022). https://www.gavi.org/vaccineswork/covid-19-vaccine-race#phases. Accessed 06-04-2023.
166. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 155. Geneva: World Health Organization; 2020. p. 1-18.
167. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 160. Geneva: World Health Organization; 2020. p. 1-16.
168. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 161. Geneva: World Health Organization; 2020. p. 1-16.
169. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 162. Geneva: World Health Organization; 2020. p. 1-17.
170. World Health Organization. Global scientific community unites to track progress on COVID-19 R&D, identifies new research priorities and critical gaps. (2020). https://www.who.int/news-room/feature-stories/detail/global-scientific-community-unites-to-track-progress-on-covid-19-r-d-identifies-new-research-priorities-and-critical-gaps. Accessed 06-04-2023.
171. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Additional COVID-19 Combination Diagnostic Test Ahead of Flu Season. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-covid-19-combination-diagnostic-test-ahead-flu. Accessed 06-04-2023.
172. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 167. Geneva: World Health Organization; 2020. p. 1-16.
173. World Health Organization. WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19. (2020). https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19. Accessed 06-04-2023.
174. Morawska L, Milton DK. It is time to address airborne transmission of coronavirus disease 2019 (COVID-19). Clinical Infectious Diseases. 2020;71(9):2311-3. https://doi.org/10.1093/cid/ciaa939.
175. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 170. Geneva: World Health Organization; 2020. p. 1-16.
176. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 172. Geneva: World Health Organization; 2020. p. 1-19.
177. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 173. Geneva: World Health Organization; 2020. p. 1-16.
178. World Health Organization. Independent evaluation of global COVID-19 response announced. (2020). https://www.who.int/news-room/detail/09-07-2020-independent-evaluation-of-global-covid-19-response-announced. Accessed 06-04-2023.
179. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 177. Geneva: World Health Organization; 2020. p. 1-18.
180. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 178. Geneva: World Health Organization; 2020. p. 1-17.
181. World Health Organization. More than 150 countries engaged in COVID-19 vaccine global access facility. (2020). https://www.who.int/news-room/detail/15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility. Accessed 06-04-2023.
182. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-authorization-sample-pooling-diagnostic. Accessed 06-04-2023.
183. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 181. Geneva: World Health Organization; 2020. p. 1-16.
184. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 182. Geneva: World Health Organization; 2020. p. 1-21.
185. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 185. Geneva: World Health Organization; 2020. p. 1-20.
186. World Health Organization African Region. WHO, Africa CDC in joint push for COVID-19 traditional medicine research in Africa. (2020). https://www.afro.who.int/news/who-africa-cdc-joint-push-covid-19-traditional-medicine-research-africa. Accessed 06-04-2023.
187. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or. Accessed 06-04-2023.
188. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 188. Geneva: World Health Organization; 2020. p. 1-16.
189. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 189. Geneva: World Health Organization; 2020. p. 1-18.
190. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 194. Geneva: World Health Organization; 2020. p. 1-16.
191. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 193. Geneva: World Health Organization; 2020. p. 1-17.
192. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-tests-estimate-patients-antibodies-past-sars-cov-2. Accessed 06-04-2023.
193. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 203. Geneva: World Health Organization; 2020. p. 1-21.
194. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 197. Geneva: World Health Organization; 2020. p. 1-18.
195. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 199. Geneva: World Health Organization; 2020. p. 1-18.
196. Pan American Health Organization. PAHO warns against use of chlorine products as treatments for COVID-19. (2020). https://www.paho.org/en/news/5-8-2020-paho-warns-against-use-chlorine-products-treatments-covid-19. Accessed 06-04-2023.
197. World Health Organization. The COVAX facility: Global procurement for COVID-19 vaccines. 2020. p. 1-6.
198. World Health Organization. COVAX, the ACT-Accelerator vaccines pillar: Insuring accelerated vaccine development and manufacture. 2020. p. 1-6.
199. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 201. Geneva: World Health Organization; 2020. p. 1-16.
200. Trump Whitehouse - National Archives. Remarks by President Trump in Press Briefing | August 11, 2020. (2020). https://trumpwhitehouse.archives.gov/briefings-statements/remarks-president-trump-press-briefing-august-11-2020/. Accessed 06-04-2023.
201. Ullah Z, Rahim Z, CNN. Putin says Russia has approved ‘world first’ Covid-19 vaccine. But questions over its safety remain. (2020). https://edition.cnn.com/2020/08/11/europe/russia-coronavirus-vaccine-putin-intl/index.html. Accessed 06-04-2023.
202. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 205. Geneva: World Health Organization; 2020. p. 1-19.
203. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 208. Geneva: World Health Organization; 2020. p. 1-16.
204. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-yale-school-public-health. Accessed 06-04-2023.
205. World Health Organization. Weekly epidemiological update - 24 August 2020. Geneva: World Health Organization; 2020. p. 1-27.
206. World Health Organization. WHO Director-General's opening remarks at the Member State briefing on COVID-19 - 20 August 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-briefing-on-covid-19---20-august-2020. Accessed 06-04-2023.
207. World Health O, United Nations Children's F. Advice on the use of masks for children in the community in the context of COVID-19: annex to the advice on the use of masks in the context of COVID-19, 21 August 2020. Geneva: World Health Organization; 2020.
208. U.S. Food and Drug Administration. FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic. (2020). https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-convalescent-plasma-potential-promising-covid-19-treatment. Accessed 06-04-2023.
209. Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection. BMJ. 2020;370:m3340. https://doi.org/10.1136/bmj.m3340.
210. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 24 August 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---24-august-2020. Accessed 06-04-2023.
211. U.S. Food and Drug Administration. COVID-19 Update: FDA Authorizes First Diagnostic Test Where Results Can Be Read Directly From Testing Card. (2020). https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-authorizes-first-diagnostic-test-where-results-can-be-read-directly-testing-card. Accessed 06-04-2023.
212. World Health Organization. Weekly epidemiological update - 31 August 2020. Geneva: World Health Organization; 2020. p. 1-22.
213. U.S. Food and Drug Administration. COVID-19 Update: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-broadens-emergency-use-authorization-veklury-remdesivir-include-all-hospitalized. Accessed 06-04-2023.
214. World Health Organization. Weekly epidemiological update - 7 September 2020. Geneva: World Health Organization; 2020. p. 1-22.
215. World Health Organization. Weekly epidemiological update- 14 September 2020. Geneva: World Health Organization; 2020. p. 1-22.
216. World Health Organization. Weekly epidemiological update - 21 September 2020. Geneva: World Health Organization; 2020. p. 1-23.
217. World Health Organization. WHO at the high-level session of the 75th UN General Assembly (UNGA). (2020). https://www.who.int/news-room/events/detail/2020/09/15/default-calendar/who-at-the-high-level-session-of-the-75th-un-general-assembly-(unga). Accessed 06-04-2023.
218. The Independent Panel for Pandemic Preparedness and Response. About the Independent Panel. (2020). https://theindependentpanel.org/about-the-independent-panel/. Accessed 06-04-2023.
219. World Health Organization. WHO SAGE Seasonal Influenza Vaccination Recommendations during the COVID-19 Pandemic. 2020. p. 1-4.
220. World Health Organization. Weekly epidemiological update - 5 October 2020. Geneva: World Health Organization; 2020. p. 1-24.
221. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Point-of-Care Antibody Test for COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-point-care-antibody-test-covid-19. Accessed 06-04-2023.
222. World Health Organization. Weekly epidemiological update - 28 September 2020. Geneva: World Health Organization; 2020. p. 1-23.
223. World Health Organization. Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries. (2020). https://www.who.int/news/item/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countries. Accessed 06-04-2023.
224. World Health Organization. UN welcomes nearly $1 billion in recent pledges - to bolster access to lifesaving tests, treatments and vaccines to end COVID-19. (2020). https://www.who.int/news/item/30-09-2020-un-welcomes-nearly-1-billion-in-recent-pledges-to-bolster-access-to-lifesaving-tests-treatments-and-vaccines-to-end-covid-19. Accessed 06-04-2023.
225. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 2 October 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---2-october-2020. Accessed 06-04-2023.
226. Trump Whitehouse - National Archives. Memorandum from the President’s Physician. (2020). https://trumpwhitehouse.archives.gov/briefings-statements/memorandum-presidents-physician-101220/. Accessed 06-04-2023.
227. Trump Whitehouse - National Archives. Memorandum from Vice President Pence’s Physician. (2020). https://trumpwhitehouse.archives.gov/briefings-statements/memorandum-vice-president-pences-physician/. Accessed 06-04-2023.
228. World Health Organization. Weekly epidemiological update - 12 October 2020. Geneva: World Health Organization; 2020. p. 1-28.
229. World Health Organization. WHO Director-General's opening remarks at Executive Board meeting. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-executive-board-meeting. Accessed 06-04-2023.
230. World Health Organization. Weekly epidemiological update - 20 October 2020. Geneva: World Health Organization; 2020. p. 1-23.
231. CNBC. Russia approves second Covid-19 vaccine after preliminary trials. (2020). https://www.cnbc.com/2020/10/14/russia-approves-second-covid-19-vaccine-after-preliminary-trials-.html. Accessed 06-04-2023.
232. World Health Organization. Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time. (2020). https://www.who.int/news/item/15-10-2020-solidarity-therapeutics-trial-produces-conclusive-evidence-on-the-effectiveness-of-repurposed-drugs-for-covid-19-in-record-time. Accessed 06-04-2023.
233. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 16 October 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-october-2020. Accessed 06-04-2023.
234. World Health Organization. Kim Sledge and the World We Want partner with WHO Foundation to re-record unity anthem “We Are Family” in response to COVID-19 and to focus on global public health needs. (2020). https://www.who.int/news/item/19-10-2020-kim-sledge-and-the-world-we-want-partner-with-who-foundation-to-re-record-unity-anthem-we-are-family-in-response-to-covid-19-and-to-focus-on-global-public-health-needs. Accessed 06-04-2023.
235. U.S. Food and Drug Administration. FDA Approves First Treatment for COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19. Accessed 06-04-2023.
236. World Health Organization. Weekly epidemiological update - 27 October 2020. Geneva: World Health Organization; 2020. p. 1-23.
237. World Health Organization. Weekly epidemiological update - 3 November 2020. Geneva: World Health Organization; 2020. p. 1-25.
238. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 30 October 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---30-october-2020. Accessed 06-04-2023.
239. World Health Organization. Weekly epidemiological update - 10 November 2020. Geneva: World Health Organization; 2020. p. 1-23.
240. Polio Global Eradication Initiative. UNICEF and WHO call for emergency action to avert major measles and polio epidemics. (2020). https://polioeradication.org/news-post/unicef-and-who-call-for-emergency-action-to-avert-major-measles-and-polio-epidemics/. Accessed 06-04-2023.
241. World Health Organization. WHO-ICMRA joint statement on the need for improved global regulatory alignment on COVID-19 medicines and vaccines. (2020). https://www.who.int/news/item/06-11-2020-who-icmra-joint-statement-on-the-need-for-improved-global-regulatory-alignment-on-covid-19-medicines-and-vaccines. Accessed 06-04-2023.
242. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-test-detects-neutralizing-antibodies-recent-or. Accessed 06-04-2023.
243. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: November 9, 2020. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-november-9-2020. Accessed 06-04-2023.
244. Pfizer. Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study. (2020). https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against. Accessed 06-04-2023.
245. World Health Organization. Access to COVID-19 Tools Accelerator commitments reach US$ 5.1billion following new contributions, including at Paris Peace Forum. (2020). https://www.who.int/news/item/13-11-2020-access-to-covid-19-tools-accelerator-commitments-reach-us-5.1billion-following-new-contributions-including-at-paris-peace-forum. Accessed 06-04-2023.
246. Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine. 2020;384(5):403-16. https://doi.org/10.1056/NEJMoa2035389.
247. World Health Organization. Weekly epidemiological update - 17 November 2020. Geneva: World Health Organization; 2020. p. 1-23.
248. World Health Organization. Weekly epidemiological update - 24 November 2020. Geneva: World Health Organization; 2020. p. 1-23.
249. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-self-testing-home. Accessed 06-04-2023.
250. Pfizer. Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints. (2020). https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine. Accessed 06-04-2023.
251. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine. 2020;383(27):2603-15. https://doi.org/10.1056/NEJMoa2034577.
252. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19. Accessed 06-04-2023.
253. World Health O. Therapeutics and COVID-19: living guideline, 20 November 2020. Geneva: World Health Organization; 2020.
254. World Health Organization. WHO Director-General's opening remarks at the G20 Leaders Summit. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-g20-leaders-summit. Accessed 06-04-2023.
255. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19. Accessed 06-04-2023.
256. World Health Organization. Weekly epidemiological update - 1 December 2020. Geneva: World Health Organization; 2020. p. 1-22.
257. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 27 November 2020. (2020). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---27-november-2020. Accessed 06-04-2023.
258. World Health Organization. COVID-19 - Denmark. (2020). https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON301. Accessed 06-04-2023.
259. World Health Organization. WHO at the Special Session of the United Nations General Assembly in Response to the Coronavirus Disease (COVID-19) Pandemic. (2020). https://www.who.int/news-room/events/detail/2020/12/03/default-calendar/who-at-the-special-session-of-the-united-nations-general-assembly-in-response-to-the-coronavirus-disease-(covid-19)-pandemic. Accessed 06-04-2023.
260. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 and Flu Combination Test for use with home-collected samples. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-and-flu-combination-test-use-home. Accessed 06-04-2023.
261. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Direct-to-Consumer COVID-19 Test System. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-direct-consumer-covid-19-test-system. Accessed 06-04-2023.
262. U.S. Food and Drug Administration. FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine. (2020). https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19. Accessed 06-04-2023.
263. World Health Organization. Weekly epidemiological update - 22 December 2020. Geneva: World Health Organization; 2020. p. 1-21.
264. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over-counter-fully-home-diagnostic. Accessed 06-04-2023.
265. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test. (2020). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-authorization-binaxnow-covid-19-ag-card-home-test. Accessed 06-04-2023.
266. World Health Organization. COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021. (2020). https://www.who.int/news/item/18-12-2020-covax-announces-additional-deals-to-access-promising-covid-19-vaccine-candidates-plans-global-rollout-starting-q1-2021. Accessed 06-04-2023.
267. World Health Organization. Weekly epidemiological update - 29 December 2020. Geneva: World Health Organization, ; 2020. p. 1-17.
268. World Health Organization. Tracking SARS-CoV-2 variants. (2020). https://www.who.int/activities/tracking-SARS-CoV-2-variants. Accessed 03-04-2023.
269. U.S. Food and Drug Administration. FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. (2020). https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid. Accessed 06-04-2023.
270. World Health Organization. COVID-19 - United Kingdom of Great Britain and Northern Ireland. (2020). https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON304. Accessed 06-04-2023.
271. World Health Organization. International Day of Epidemic Preparedness. (2020). https://www.who.int/news-room/events/detail/2020/12/27/default-calendar/international-day-of-epidemic-preparedness. Accessed 06-04-2023.
272. AstraZeneca. AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK. (2020). https://www.astrazeneca.com/media-centre/press-releases/2020/astrazenecas-covid-19-vaccine-authorised-in-uk.html#! Accessed 06-04-2023.
273. World Health Organization. COVID-19 - Global. (2020). https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON305. Accessed 06-04-2023.
274. World Health Organization. Weekly epidemiological update - 12 January 2021. Geneva: World Health Organization; 2021. p. 1-20.
275. World Health Organization. WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. (2020). https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access. Accessed 06-04-2023.
276. National Medical Products Administration. China grants conditional approval for first COVID vaccine. (2020). http://subsites.chinadaily.com.cn/nmpa/2020-12/31/c_579192.htm. Accessed 06-04-2023.
277. Biotech H. G42 announces new JV with Sinopharm CNBG to produce Hayat-Vax vaccine in the UAE. (2020). https://hayatbiotech.com/g42-announces-new-jv-with-sinopharm-cnbg-to-produce-hayat-vax-vaccine-in-the-uae/. Accessed 06-04-2023.
278. World Health Organization. Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) - 5 January 2021. (2021). https://www.who.int/news-room/events/detail/2021/01/05/default-calendar/extraordinary-meeting-of-the-strategic-advisory-group-of-experts-on-immunization-(sage)---5-january-2021. Accessed 06-04-2023.
279. World Health Organization. WHO Director-General's opening remarks at the Member States briefing on COVID-19 - 7 January 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-states-briefing-on-covid-19---7-january-2021. Accessed 06-04-2023.
280. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 8 January 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-8-january-2021. Accessed 06-04-2023.
281. World Health Organization. Weekly epidemiological update - 19 January 2021. Geneva: World Health Organization; 2021. p. 1-23.
282. World Health Organization. Global scientists double down on SARS-CoV-2 variants research at WHO-hosted forum. (2021). https://www.who.int/news/item/12-01-2021-global-scientists-double-down-on-sars-cov-2-variants-research-at-who-hosted-forum. Accessed 06-04-2023.
283. World Health Organization. 5th Open meeting of the Review Committee on the Functioning of the International Health Regulations during COVID-19. (2021). https://www.who.int/director-general/speeches/detail/5th-open-meeting-of-the-review-committee-on-the-functioning-of-the-international-health-regulations-during-covid-19. Accessed 07-04-2023.
284. World Health Organization. Statement on the sixth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. (2021). https://www.who.int/news/item/15-01-2021-statement-on-the-sixth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 07-04-2023.
285. World Health Organization. Emergency Committee on COVID-19 advises on variants, vaccines. (2021). https://www.who.int/news/item/15-01-2021-emergency-committee-on-covid-19-advises-on-variants-vaccines. Accessed 07-04-2023.
286. World Health Organization. WHO Director-General's opening remarks at the 6th Meeting of the IHR Emergency Committee on COVID-19. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-6th-meeting-of-the-ihr-emergency-committee-on-covid-19. Accessed 07-04-2023.
287. World Health Organization. Scientists tackle vaccine safety, efficacy and access at global R&D forum. (2021). https://www.who.int/news/item/16-01-2021-scientists-tackle-vaccine-safety-efficacy-and-access-at-global-r-d-forum. Accessed 07-04-2023.
288. World Health Organization. WHO Director-General's opening remarks at 148th session of the Executive Board. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-148th-session-of-the-executive-board. Accessed 07-04-2023.
289. World Health Organization. Weekly epidemiological update - 27 January 2021. Geneva: World Health Organization; 2021. p. 1-22.
290. World Health Organization. Weekly epidemiological update - 2 February 2021. Geneva: World Health Organization; 2021. p. 1-25.
291. World Health Organization. GACVS COVID-19 Vaccine Safety subcommittee meeting to review reports of deaths of very frail elderly individuals vaccinated with Pfizer BioNTech COVID-19 vaccine, BNT162b2. (2021). https://www.who.int/news/item/22-01-2021-gacvs-review-deaths-pfizer-biontech-covid-19-vaccine-bnt162b2. Accessed 07-04-2023.
292. The White House. A National Day of Unity. (2021). https://www.whitehouse.gov/briefing-room/presidential-actions/2021/01/20/a-national-day-of-unity/. Accessed 07-04-2023.
293. World Health Organization. WHO Director-General's remarks at the 148th session of the Executive Board. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-148th-session-of-the-executive-board. Accessed 07-04-2023.
294. World Health Organization. COVAX Announces new agreement, plans for first deliveries. (2021). https://www.who.int/news/item/22-01-2021-covax-announces-new-agreement-plans-for-first-deliveries. Accessed 07-04-2023.
295. World Health Organization. Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) - 21 January 2021. (2021). https://www.who.int/news-room/events/detail/2021/01/21/default-calendar/extraordinary-meeting-of-the-strategic-advisory-group-of-experts-on-immunization-(sage)---21-january-2021. Accessed 07-04-2023.
296. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 5 February 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-5-february-2021. Accessed 07-04-2023.
297. Sanofi. Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs. (2021). https://www.sanofi.com/en/media-room/press-releases/2021/2021-01-27-06-30-00-2164797. Accessed 07-04-2023.
298. World Health Organization. WHO publishes new Essential Diagnostics List and urges countries to prioritize investments in testing. (2021). https://www.who.int/news/item/29-01-2021-who-publishes-new-essential-diagnostics-list-and-urges-countries-to-prioritize-investments-in-testing. Accessed 07-04-2023.
299. World Health Organization. Weekly epidemiological update - 9 February 2021. Geneva: World Health Organization; 2021. p. 1-28.
300. World Health Organization. FIFA and WHO #ACTogether to tackle COVID-19. (2021). https://www.who.int/news/item/01-02-2021-fifa-and-who-actogether-to-tackle-covid-19. Accessed 07-04-2023.
301. World Health Organization. WHO SCORE Global Report highlights urgent need for better data to strengthen pandemic response and improve health outcomes. (2021). https://www.who.int/news/item/01-02-2021-who-score-global-report-highlights-urgent-need-for-better-data-to-strengthen-pandemic-response-and-improve-health-outcomes. Accessed 07-04-2023.
302. World Health Organization. COVAX publishes first interim distribution forecast. (2021). https://www.who.int/news/item/03-02-2021-covax-publishes-first-interim-distribution-forecast. Accessed 07-04-2023.
303. World Health Organization. WHO Director-General's opening remarks at the Member States briefing on COVID-19 - 4 February 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-states-briefing-on-covid-19---4-february-2021. Accessed 07-04-2023.
304. World Health Organization. Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers. (2021). https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers. Accessed 07-04-2023.
305. World Health Organization. Weekly epidemiological update - 16 February 2021. Geneva: World Health Organization; 2021. p. 1-26.
306. World Health Organization. COVAX Statement on New Variants of SARS-CoV-2. (2021). https://www.who.int/news/item/08-02-2021-covax-statement-on-new-variants-of-sars-cov-2. Accessed 07-04-2023.
307. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19-0. Accessed 07-04-2023.
308. World Health Organization. In the COVID-19 vaccine race, we either win together or lose together. (2021). https://www.who.int/news/item/10-02-2021-in-the-covid-19-vaccine-race-we-either-win-together-or-lose-together. Accessed 07-04-2023.
309. World Health Organization. Methodological approaches to assess variants effect on vaccine efficacy, effectiveness and impact. 2021. p. 1-22.
310. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 12 February 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-12-february-2021. Accessed 07-04-2023.
311. World Health Organization. Weekly epidemiological update - 23 February 2021. Geneva: World Health Organization; 2021. p. 1-33.
312. World Health Organization. COVAX Statement on WHO Emergency Use Listing for AstraZeneca/Oxford COVID-19 Vaccine. (2021). https://www.who.int/news/item/16-02-2021-covax-statement-on-who-emergency-use-listing-for-astrazeneca-oxford-covid-19-vaccine. Accessed 07-04-2023.
313. World Health Organization. Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic. 2021. p. 1-10.
314. World Health Organization. G7 leaders commit US$ 4.3 billion to finance global equitable access to tests, treatments and vaccines in 2021. (2021). https://www.who.int/news/item/19-02-2021-g7-leaders-commit-us-4.3-billion-to-finance-global-equitable-access-to-tests-treatments-and-vaccines-in-2021. Accessed 07-04-2023.
315. Radio Free Europe/Radio Liberty. Russia Approves CoviVac, Its Third Coronavirus Vaccine. (2021). https://www.rferl.org/a/russia-coronavirus-vaccine-covivac/31113697.html. Accessed 07-04-2023.
316. World Health Organization. World Pharmacopoeias support public health during COVID-19 pandemic. (2021). https://www.who.int/news/item/01-03-2021-world-pharmacopoeias-support-public-health-during-covid-19-pandemic. Accessed 07-04-2023.
317. World Health Organization. Weekly epidemiological update - 2 March 2021. Geneva: World Health Organization; 2021. p. 1-31.
318. World Health Organization. Weekly epidemiological update - 25 February 2021. Geneva: World Health Organization; 2021. p. 1-4.
319. World Health Organization. COVID-19 oxygen emergency impacting more than half a million people in low- and middle-income countries every day, as demand surges. (2021). https://www.who.int/news/item/25-02-2021-covid-19-oxygen-emergency-impacting-more-than-half-a-million-people-in-low--and-middle-income-countries-every-day-as-demand-surges. Accessed 07-04-2023.
320. World Health Organization. GACVS COVID-19 Vaccine Safety subcommittee meeting to review reports on influenza-like illness in individuals vaccinated with COVID-19 vaccines. (2021). https://www.who.int/news/item/08-03-2021-gacvs-covid-19-review-influenza-like-illness. Accessed 07-04-2023.
321. U.S. Food and Drug Administration. FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine. (2021). https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine. Accessed 07-04-2023.
322. World Health Organization. Weekly epidemiological update - 9 March 2021. Geneva: World Health Organization; 2021. p. 1-33.
323. World Health Organization. First COVID-19 COVAX vaccine doses administered in Africa. (2021). https://www.who.int/news/item/01-03-2021-first-covid-19-covax-vaccine-doses-administered-in-africa. Accessed 07-04-2023.
324. Wu H, Associated Press News. China approves another COVID-19 vaccine for emergency use. (2021). https://apnews.com/article/science-biology-clinical-trials-microbiology-coronavirus-pandemic-25b1d6227a0921038a0dbded2c7dfb6c. Accessed 07-04-2023.
325. World Health Organization. COVAX publishes first round of allocations. (2021). https://www.who.int/news/item/02-03-2021-covax-publishes-first-round-of-allocations. Accessed 07-04-2023.
326. World Health Organization. WHO Director-General's opening remarks at Member States Information Session on COVID-19 – 4 March 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-states-information-session-on-covid-19-4-march-2021. Accessed 07-04-2023.
327. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues Authorization for First Molecular Non-Prescription, At-Home Test. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-authorization-first-molecular-non-prescription-home-test. Accessed 07-04-2023.
328. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-adaptive-biotechnologies-t-detect-covid-test. Accessed 07-04-2023.
329. Howard J, Christensen J, CNN. FDA warns against using anti-parasitic drug for Covid-19 after reports of hospitalizations. (2021). https://edition.cnn.com/2021/03/05/health/ivermectin-covid-19-fda-statement-wellness/index.html. Accessed 07-04-2023.
330. World Health Organization. WHO R&D Blueprint: Consultation on the use of trained dogs for screening COVID-19 cases. Geneva 2021. p. 1-10.
331. World Health Organization. Weekly epidemiological update on COVID-19 – 16 March 2021. Geneva: World Health Organization; 2021. p. 1-28.
332. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 12 March 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-12-march-2021. Accessed 07-04-2023.
333. World Health Organization. COVID-19 Solidarity Response Fund marks first anniversary and appeals for continued support. (2021). https://www.who.int/news/item/15-03-2021-covid-19-solidarity-response-fund-marks-first-anniversary-and-appeals-for-continued-support. Accessed 07-04-2023.
334. World Health Organization. Weekly epidemiological update on COVID-19 - 23 March 2021. Geneva: World Health Organization; 2021. p. 1-31.
335. U.S. Food and Drug Administration. FDA Permits Marketing of First SARS-CoV-2 Diagnostic Test Using Traditional Premarket Review Process. (2021). https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-sars-cov-2-diagnostic-test-using-traditional-premarket-review-process. Accessed 07-04-2023.
336. World Health Organization. Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine. (2021). https://www.who.int/news/item/19-03-2021-statement-of-the-who-global-advisory-committee-on-vaccine-safety-(gacvs)-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine. Accessed 07-04-2023.
337. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Machine Learning-Based Screening Device to Identify Certain Biomarkers That May Indicate COVID-19 Infection. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-machine-learning-based-screening-device-identify. Accessed 07-04-2023.
338. World Health Organization. Weekly epidemiological update on COVID-19 - 30 March 2021. Geneva: World Health Organization; 2021. p. 1-28.
339. World Health Organization. COVAX updates participants on delivery delays for vaccines from Serum Institute of India (SII) and AstraZeneca. (2021). https://www.who.int/news/item/25-03-2021-covax-updates-participants-on-delivery-delays-for-vaccines-from-serum-institute-of-india-(sii)-and-astrazeneca. Accessed 07-04-2023.
340. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 26 March 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-26-march-2021. Accessed 07-04-2023.
341. World Health Organization. Global Consultation on a Decision Framework for Assessing the Impact of SARS-CoV-2 Variants of Concern on Public Health Interventions. (2021). https://www.who.int/news-room/events/detail/2021/03/29/default-calendar/global-consultation-on-a-decision-framework-for-assessing-the-impact-of-sars-cov-2-variants-of-concern-on-public-health-interventions. Accessed 07-04-2023.
342. World Health Organization. WHO calls for further studies, data on origin of SARS-CoV-2 virus, reiterates that all hypotheses remain open. (2021). https://www.who.int/news/item/30-03-2021-who-calls-for-further-studies-data-on-origin-of-sars-cov-2-virus-reiterates-that-all-hypotheses-remain-open. Accessed 07-04-2023.
343. World Health Organization. Global leaders unite in urgent call for international pandemic treaty. (2021). https://www.who.int/news/item/30-03-2021-global-leaders-unite-in-urgent-call-for-international-pandemic-treaty. Accessed 07-04-2023.
344. World Health Organization. WHO advises that ivermectin only be used to treat COVID-19 within clinical trials. (2021). https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials. Accessed 07-04-2023.
345. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-advance-over-counter-and-other-screening-test-development. Accessed 07-04-2023.
346. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: April 6, 2021. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-april-6-2021. Accessed 10-04-2023.
347. World Health Organization. Weekly epidemiological update on COVID-19 - 13 April 2021. Geneva: World Health Organization; 2021. p. 1-31.
348. U.S. Food and Drug Administration. Alisson Becker and WHO Foundation launch campaign to raise resources and support treatment for COVID-19 patients starting in the Americas. (2021). https://www.who.int/news/item/07-04-2021-alisson-becker-and-who-foundation-launch-campaign-to-raise-resources-and-support-treatment-for-covid-19-patients-starting-in-the-americas. Accessed 10-04-2023.
349. World Health Organization. WHO urges countries to build a fairer, healthier world post-COVID-19. (2021). https://www.who.int/news/item/06-04-2021-who-urges-countries-to-build-a-fairer-healthier-world-post-covid-19. Accessed 10-04-2023.
350. World Health Organization. Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine. (2021). https://www.who.int/news/item/07-04-2021-interim-statement-of-the-covid-19-subcommittee-of-the-who-global-advisory-committee-on-vaccine-safety. Accessed 10-04-2023.
351. World Health Organization. COVAX reaches over 100 economies, 42 days after first international delivery. (2021). https://www.who.int/news/item/08-04-2021-covax-reaches-over-100-economies-42-days-after-first-international-delivery. Accessed 10-04-2023.
352. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 9 April 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-9-april-2021. Accessed 10-04-2023.
353. World Health Organization. Call to action: Vaccine Equity. (2021). https://www.who.int/campaigns/vaccine-equity/vaccine-equity-declaration. Accessed 10-04-2023.
354. U.S. Food and Drug Administration. Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine. (2021). https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine. Accessed 10-04-2023.
355. World Health Organization. Statement on the seventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. (2021). https://www.who.int/news/item/19-04-2021-statement-on-the-seventh-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 10-04-2023.
356. World Health Organization. Weekly epidemiological update on COVID-19 - 20 April 2021. Geneva: World Health Organization; 2021. p. 1-30.
357. World Health Organization. Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield). (2021). https://www.who.int/news/item/16-04-2021-global-advisory-committee-on-vaccine-safety-(gacvs)-review-of-latest-evidence-of-rare-adverse-blood-coagulation-events-with-astrazeneca-covid-19-vaccine-(vaxzevria-and-covishield). Accessed 10-04-2023.
358. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab. Accessed 10-04-2023.
359. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 19 April 2021. (2021). https://www.who.int/director-general/speeches/detail/director-generals-opening-remarks-at-the-media-briefing-on-covid-19-19-april-2021. Accessed 10-04-2023.
360. World Health Organization. Weekly epidemiological update on COVID-19 - 27 April 2021. Geneva: World Health Organization; 2021. p. 1-30.
361. World Health Organization. Asthma and COVID-19: scientific brief, 19 April 2021. 2021. p. 1-4.
362. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 23 April 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-23-april-2021. Accessed 10-04-2023.
363. U.S. Food and Drug Administration. FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review. (2021). https://www.fda.gov/news-events/press-announcements/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough. Accessed 10-04-2023.
364. World Health Organization. Expanding our understanding of post COVID-19 condition: report of a WHO webinar - 9 February 2021. 2021. p. 1-36.
365. Batyrov A, Caspian News. Kazakhstan Launches Production of First Homegrown Vaccine, ‘QazVac’. (2021). https://caspiannews.com/news-detail/kazakhstan-launches-production-of-first-homegrown-vaccine-qazvac-2021-4-25-0/. Accessed 10-04-2023.
366. World Health Organization. Weekly epidemiological update on COVID-19 - 4 May 2021. Geneva: World Health Organization; 2021. p. 1-30.
367. World Health Organization. WHO lists Moderna vaccine for emergency use. (2021). https://www.who.int/news/item/30-04-2021-who-lists-moderna-vaccine-for-emergency-use. Accessed 10-04-2023.
368. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 3 May 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-3-may-2021. Accessed 11-04-2023.
369. World Health Organization. Weekly epidemiological update on COVID-19 - 11 May 2021. Geneva: World Health Organization; 2021. p. 1-32.
370. World Health Organization. WHO, Germany launch new global hub for pandemic and epidemic intelligence. (2021). https://www.who.int/news/item/05-05-2021-who-germany-launch-new-global-hub-for-pandemic-and-epidemic-intelligence. Accessed 11-04-2023.
371. World Health Organization. Joint Statement on transparency and data integrity International Coalition of Medicines Regulatory Authorities (ICMRA) and WHO. (2021). https://www.who.int/news/item/07-05-2021-joint-statement-on-transparency-and-data-integrityinternational-coalition-of-medicines-regulatory-authorities-(icmra)-and-who. Accessed 11-04-2023.
372. World Health Organization. WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations. (2021). https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations. Accessed 11-04-2023.
373. World Health O. COVID-19 natural immunity: scientific brief, 10 May 2021. Geneva: World Health Organization; 2021.
374. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use. Accessed 11-04-2023.
375. World Health Organization. Weekly epidemiological update on COVID-19 - 18 May 2021. Geneva: World Health Organization; 2021. p. 1-28.
376. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 14 May 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-14-may-2021. Accessed 11-04-2023.
377. World Health Organization. WHO R&D Blueprint COVID-19: Infection Prevention and Control (IPC) Pillar Achievements. 2021. p. 1-55.
378. Reuters. Kangtai Biological's COVID-19 vaccine gets emergency use approval in China. (2021). https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai-idUSKBN2CV1F6. Accessed 11-04-2023.
379. World Health Organization. Weekly epidemiological update on COVID-19 - 25 May 2021. Geneva: World Health Organization; 2021. p. 1-31.
380. World Health Organization, International Labour Organization. Preventing and mitigating COVID-19 at work: policy brief, 19 May 2021. 2021. p. 1-21.
381. World Health Organization. Statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on safety signals related to the Johnson & Johnson/Janssen COVID-19 vaccine. (2021). https://www.who.int/news/item/19-05-2021-statement-gacvs-safety-johnson-johnson-janssen-covid-19-vaccine. Accessed 11-04-2023.
382. U.S. Food and Drug Administration. FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination. (2021). https://www.fda.gov/news-events/press-announcements/fda-brief-fda-advises-against-use-sars-cov-2-antibody-test-results-evaluate-immunity-or-protection. Accessed 11-04-2023.
383. World Health Organization. Support to countries’ equitable and resilient recovery from the pandemic towards the health SDGs: The 2021 SDG3 GAP progress report. (2021). https://www.who.int/news/item/20-05-2021-support-to-countries-equitable-and-resilient-recovery-from-the-pandemic-towards-the-health-sdgs-the-2021-sdg3-gap-progress-report. Accessed 11-04-2023.
384. World Health Organization. New international expert panel to address the emergence and spread of zoonotic diseases. (2021). https://www.who.int/news/item/20-05-2021-new-international-expert-panel-to-address-the-emergence-and-spread-of-zoonotic-diseases. Accessed 11-04-2023.
385. World Health Organization. Director-General's opening remarks at the World Health Assembly - 24 May 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-world-health-assembly---24-may-2021. Accessed 11-04-2023.
386. World Health Organization. WHO and Switzerland launch global BioHub for pathogen storage, sharing and analysis. (2021). https://www.who.int/news/item/24-05-2021-who-and-switzerland-launch-global-biohub-for-pathogen-storage-sharing-and-analysis. Accessed 11-04-2023.
387. World Health Organization. Weekly epidemiological update on COVID-19 - 1 June 2021. Geneva: World Health Organization; 2021. p. 1-28.
388. World Health Organization. Director-General’s closing remarks at the World Health Assembly - 31 May 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-closing-remarks-at-the-world-health-assembly---31-may-2021. Accessed 11-04-2023.
389. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-treatment-covid-19. Accessed 11-04-2023.
390. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 28 May 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-28-may-2021. Accessed 11-04-2023.
391. World Health Organization. A New Commitment for Vaccine Equity and Defeating the Pandemic. (2021). https://www.who.int/news-room/commentaries/detail/a-new-commitment-for-vaccine-equity-and-defeating-the-pandemic. Accessed 11-04-2023.
392. World Health Organization. Weekly epidemiological update on COVID-19 - 8 June 2021. Geneva: World Health Organization; 2021. p. 1-29.
393. World Health Organization. WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations. (2021). https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations. Accessed 11-04-2023.
394. World Health Organization, United Nations Children's Fund. Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines: interim guidance, 1 June 2021. Geneva: World Health Organization; 2021.
395. World Health Organization. Weekly epidemiological update on COVID-19 - 15 June 2021. Geneva: World Health Organization; 2021. p. 1-26.
396. World Health Organization. 149th session of the Executive Board. (2021). https://www.who.int/about/governance/executive-board/executive-board-149th-session. Accessed 11-04-2023.
397. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 7 June 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-7-june-2021. Accessed 11-04-2023.
398. Shumei L, Global Times. China approves 7th self-developed COVID-19 vaccine, can cross-neutralize variants. (2021). https://www.globaltimes.cn/page/202106/1225877.shtml. Accessed 11-04-2023.
399. Reuters. China builds new plant for IMBCAMS COVID-19 vaccine -state media. (2021). https://www.reuters.com/world/asia-pacific/china-builds-new-plant-imbcams-covid-19-vaccine-state-media-2021-06-09/. Accessed 11-04-2023.
400. World Health Organization. Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness (Revised 11 June 2021). (2021). https://www.icmra.info/drupal/en/covid-19/icmra_who_vaccines_confidence_statement_for_hcps. Accessed 11-04-2023.
401. World Health Organization. Director-General's opening remarks at the G7 Summit - 12 June 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-g7-summit---12-june-2021. Accessed 11-04-2023.
402. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 14 June 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-14-june-2021. Accessed 11-04-2023.
403. World Health O. Considerations for implementing and adjusting public health and social measures in the context of COVID-19: interim guidance, 14 June 2021. Geneva: World Health Organization; 2021.
404. Radio Free Europe/Radio Liberty. Iran Approves Emergency Use Of Domestic COVID Vaccine. (2021). https://www.rferl.org/a/iran-domestic-covid-vaccine-coviran-barekat/31307467.html. Accessed 11-04-2023.
405. World Health Organization. Weekly epidemiological update on COVID-19 - 22 June 2021. Geneva: World Health Organization; 2021. p. 1-23.
406. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 21 June 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-16-june-2021. Accessed 11-04-2023.
407. World Health Organization. Director-General's opening remarks at World Local Production Forum: Enhancing access to medicines and other health technologies - 21 June 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-world-local-production-forum-enhancing-access-to-medicines-and-other-health-technologies---21-june-2021. Accessed 11-04-2023.
408. World Health Organization. Weekly epidemiological update on COVID-19 - 29 June 2021. Geneva: World Health Organization; 2021. p. 1-19.
409. World Health Organization. Director-General's introductory remarks at the high-level event: The Role of Primary Health Care in the COVID-19 Pandemic response and leading equitable recovery. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-introductory-remarks-at-the-high-level-event-the-role-of-primary-health-care-in-the-covid-19-pandemic-response-and-leading-equitable-recovery. Accessed 11-04-2023.
410. World Health Organization. Directors General of WHO, WIPO and the WTO agree on intensified cooperation in support of access to medical technologies worldwide to tackle the COVID-19 pandemic. (2021). https://www.who.int/news/item/24-06-2021-directors-general-of-who-wipo-and-the-wto-agree-on-intensified-cooperation-in-support-of-access-to-medical-technologies-worldwide-to-tackle-the-covid-19-pandemic. Accessed 11-04-2023.
411. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19. Accessed 11-04-2023.
412. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 25 June 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-25-june-2021. Accessed 11-04-2023.
413. World Health O. Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities: interim guidance, 25 June 2021. Geneva: World Health Organization; 2021.
414. World Health O, European Centre for Disease P, Control. Indicator framework for the evaluation of the public health effectiveness of digital proximity tracing solutions. Geneva: World Health Organization; 2021.
415. World Health Organization. Weekly epidemiological update on COVID-19 - 6 July 2021. Geneva: World Health Organization; 2021. p. 1-23.
416. World Health Organization. Protocol template to be used as template for observational study protocols: sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines. Geneva: World Health Organization; 2021.
417. World Health O. Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic, 1 July 2021. Geneva: World Health Organization; 2021.
418. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 2 July 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-2-july-2021. Accessed 11-04-2023.
419. World Health O. Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: interim guidance : annex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021. Geneva: World Health Organization; 2021.
420. World Health O. Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021. Geneva: World Health Organization; 2021.
421. World Health Organization. Weekly epidemiological update on COVID-19 - 13 July 2021. Geneva: World Health Organization; 2021. p. 1-16.
422. World Health Organization. WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access. (2021). https://www.who.int/news/item/06-07-2021-who-recommends-life-saving-interleukin-6-receptor-blockers-for-covid-19-and-urges-producers-to-join-efforts-to-rapidly-increase-access. Accessed 11-04-2023.
423. World Health O. Therapeutics and COVID-19: living guideline, 6 July 2021. Geneva: World Health Organization; 2021.
424. World Health Organization. Director-General's opening remarks at the media briefing on COVID-19 – 7 July 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-7-july-2021. Accessed 11-04-2023.
425. World Health O. WHO global clinical platform for the clinical characterization of COVID-19: statistical analysis plan, 7 July 2021. Geneva: World Health Organization; 2021.
426. World Health O. COVID-19 case management capacities: diagnostics, therapeutics, vaccine readiness, and other health products – facility assessment tool: a module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, 7 July 2021. Geneva: World Health Organization; 2021.
427. World Health O. Modelling the health impacts of disruptions to essential health services during COVID-19: module 1: understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition. Geneva: World Health Organization; 2021.
428. CECMED. CECMED approves the Emergency Use Authorization of the Cuban vaccine candidate ABDALA. (2021). https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-candidato-vacunal-cubano-abdala. Accessed 11-04-2023.
429. World Health O. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed: interim guidance, 12 July 2021. Geneva: World Health Organization; 2021.
430. World Health O. COVID-19 vaccines: safety surveillance manual: module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women. Geneva: World Health Organization; 2021.
431. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: July 13, 2021. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021. Accessed 11-04-2023.
432. World Health Organization. Weekly epidemiological update on COVID-19 - 20 July 2021. Geneva: World Health Organization; 2021. p. 1-21.
433. World Health Organization. WHO Director-General's opening remarks at the 8th meeting of the IHR Emergency Committee on COVID-19 – 14 July 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-ihr-emergency-committee-on-covid-19-14-july-2021. Accessed 11-04-2023.
434. World Health O. WHO technical consultation on oxygen access scale-up for COVID-19. Geneva: World Health Organization; 2021.
435. World Health Organization. Germany reinforces its commitment to support WHO’s work. (2021). https://www.who.int/news/item/16-07-2021-germany-reinforces-its-commitment-to-support-who-s-work. Accessed 11-04-2023.
436. World Health Organization. COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows. (2021). https://www.who.int/news/item/15-07-2021-covid-19-pandemic-leads-to-major-backsliding-on-childhood-vaccinations-new-who-unicef-data-shows. Accessed 11-04-2023.
437. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on Origins. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-origins. Accessed 11-04-2023.
438. Silver A. Why Taiwan approved its own vaccine before phase III trials. BMJ. 2021;374:n2104. https://doi.org/10.1136/bmj.n2104.
439. World Health Organization. Weekly epidemiological update on COVID-19 - 27 July 2021. Geneva: World Health Organization; 2021. p. 1-18.
440. World Health Organization. WHO Director-General's opening remarks at the WTO - WHO High Level Dialogue: Expanding COVID-19 Vaccine Manufacture To Promote Equitable Access. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-wto---who-high-level-dialogue-expanding-covid-19-vaccine-manufacture-to-promote-equitable-access. Accessed 11-04-2023.
441. World Health Organization. WHO Director-General's keynote speech at the 138th International Olympic Committee Session. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-keynote-speech-at-the-138th-international-olympic-committee-session. Accessed 11-04-2023.
442. BBC. Mucormycosis: India records more than 4,300 'black fungus' deaths. (2021). https://www.bbc.com/news/world-asia-india-57897682. Accessed 01-08-2023.
443. Prakash S, Kumar A. Mucormycosis threats: A systemic review. Journal of Basic Microbiology. 2023;63(2):119-27. https://doi.org/https://doi.org/10.1002/jobm.202200334.
444. Dam P, Cardoso MH, Mandal S, et al. Surge of mucormycosis during the COVID-19 pandemic. Travel Medicine and Infectious Disease. 2023;52:102557. https://doi.org/https://doi.org/10.1016/j.tmaid.2023.102557.
445. Chowdhary A, Gupta N, Wurster S, et al. Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors. Mycoses. 2023;66(6):515-26. https://doi.org/https://doi.org/10.1111/myc.13578.
446. Asrani P, Eapen MS, Hassan MI, Sohal SS. Implications of the second wave of COVID-19 in India. The Lancet Respiratory Medicine. 2021;9(9):e93-e4. https://doi.org/https://doi.org/10.1016/S2213-2600(21)00312-X.
447. World Health Organization. Weekly epidemiological update on COVID-19 - 3 August 2021. Geneva: World Health Organization; 2021. p. 1-14.
448. World Health O. Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: interim guidance, 22 July 2021: addendum to Evaluation of COVID-19 vaccine effectiveness: interim guidance. Geneva: World Health Organization; 2021.
449. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: July 30, 2021. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-30-2021. Accessed 11-04-2023.
450. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 30 July 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-30-july-2021. Accessed 11-04-2023.
451. World Health Organization. Joint Statement of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics, and Diagnostics for Developing Countries following its Second Meeting. (2021). https://www.who.int/news/item/30-07-2021-joint-statement-of-the-multilateral-leaders-task-force-on-covid-19-vaccines-therapeutics-and-diagnostics-for-developing-countries-following-its-second-meeting. Accessed 11-04-2023.
452. World Health Organization. New consortium working to boost vaccine production in South Africa. (2021). https://www.who.int/news/item/30-07-2021-new-consortium-working-to-boost-vaccine-production-in-south-africa. Accessed 11-04-2023.
453. World Health O. Holding gatherings during the COVID-19 pandemic: WHO policy brief, 2 August 2021. Geneva: World Health Organization; 2021.
454. World Health Organization. Weekly epidemiological update on COVID-19 - 10 August 2021. Geneva: World Health Organization; 2021. p. 1-22.
455. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 4 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-4-august-2021. Accessed 11-04-2023.
456. World Health Organization. WHO Director-General's remarks at the 1st International Forum on Vaccine Cooperation - 5 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-1st-international-forum-on-vaccine-cooperation---5-august-2021. Accessed 11-04-2023.
457. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on COVID-19 - 5 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-covid-19---5-august-2021. Accessed 11-04-2023.
458. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: August 6, 2021. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-august-6-2021. Accessed 11-04-2023.
459. World Health Organization. Weekly epidemiological update on COVID-19 - 17 August 2021. Geneva: World Health Organization; 2021. p. 1-16.
460. World Health Organization. Interim statement on heterologous priming for COVID-19 vaccines. (2021). https://www.who.int/news/item/10-08-2021-interim-statement-on-heterologous-priming-for-covid-19-vaccines. Accessed 11-04-2023.
461. World Health Organization. Interim statement on dose-sparing strategies for COVID-19 vaccines (fractionated vaccine doses). (2021). https://www.who.int/news/item/10-08-2021-interim-statement-on-dose-sparing-strategies-for-covid-19-vaccines-(fractionated-vaccine-doses). Accessed 11-04-2023.
462. World Health Organization. Interim statement on COVID-19 vaccine booster doses. (2021). https://www.who.int/news/item/10-08-2021-interim-statement-on-covid-19-vaccine-booster-doses. Accessed 11-04-2023.
463. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-august-2021. Accessed 11-04-2023.
464. World Health Organization. WHO Statement on advancing the next series of studies to find the origins of SARS-CoV-2. (2021). https://www.who.int/news/item/12-08-2021-who-statement-on-advancing-the-next-series-of-studies-to-find-the-origins-of-sars-cov-2. Accessed 11-04-2023.
465. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised. Accessed 11-04-2023.
466. World Health Organization. Weekly epidemiological update on COVID-19 - 24 August 2021. Geneva: World Health Organization; 2021. p. 1-22.
467. World Health Organization. Joint Statement from Unitaid and the World Health Organization (on behalf of the Access to COVID-19 Tools Accelerator) regarding availability of tocilizumab. (2021). https://www.who.int/news/item/18-08-2021-joint-statement-from-unitaid-and-the-world-health-organization-(on-behalf-of-the-access-to-covid-19-tools-accelerator)-regarding-availability-of-tocilizumab#cms. Accessed 11-04-2023.
468. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on COVID-19 - 19 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-covid-19---19-august-2021. Accessed 11-04-2023.
469. World Health Organization. Call for experts to join Scientific Advisory Group for the Origins of Novel Pathogens. (2021). https://www.who.int/news/item/20-08-2021-call-for-experts-to-join-scientific-advisory-group-for-the-origins-of-novel-pathogens. Accessed 11-04-2023.
470. CECMED. CECMED approves the Emergency Use Authorization of the Cuban Vaccines SOBERANA 02 and SOBERANA PLUS. (2021). https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-vacunas-cubanas-soberana-02-soberana-plus. Accessed 11-04-2023.
471. Press Information Bureau Delhi. DBT-BIRAC supported ZyCoV-D developed by Zydus Cadila Receives Emergency Use Authorization. (2021). https://www.pib.gov.in/PressReleasePage.aspx?PRID=1747669. Accessed 11-04-2023.
472. U.S. Food and Drug Administration. FDA Approves First COVID-19 Vaccine. (2021). https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine. Accessed 11-04-2023.
473. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 25 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---25-august-2021. Accessed 11-04-2023.
474. World Health Organization. WHO Director-General's opening remarks at Member State Information Session on COVID-19 - 27 August 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-state-information-session-on-covid-19. Accessed 11-04-2023.
475. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: August 31, 2021. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-august-31-2021. Accessed 11-04-2023.
476. World Health Organization. Dr Michael Ryan's remarks at the launch of the WHO Hub for Pandemic and Epidemic Intelligence. (2021). https://www.who.int/director-general/speeches/detail/dr-michael-ryan-s-remarks-at-the-launch-of-the-who-hub-for-pandemic-and-epidemic-intelligence. Accessed 11-04-2023.
477. World Health Organization. WHO Director-General's opening remarks at G20 Health Ministers Meeting - 5 September 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-g20-health-ministers-meeting---5-september-2021. Accessed 11-04-2023.
478. World Health Organization. WHO Director-General's intervention at theG20 Health Ministers Meeting: Session 2. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-intervention-at-theg20-health-ministers-meeting-session-2. Accessed 11-04-2023.
479. World Health Organization. WHO Director-General's intervention at the G20 Health Ministers’ Meeting. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-intervention-at-the-g20-health-ministers-meeting. Accessed 11-04-2023.
480. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 8 September 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---8-september-2021. Accessed 11-04-2023.
481. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 14 September 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---14-september-2021. Accessed 11-04-2023.
482. U.S. Food and Drug Administration. FDA authorizes bamlanivimab and etesevimab monoclonal antibody therapy for post-exposure prophylaxis (prevention) for COVID-19. (2021). https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-bamlanivimab-and-etesevimab-monoclonal-antibody-therapy-post-exposure-prophylaxis. Accessed 11-04-2023.
483. World Health Organization. WHO Director-General's remarks at the Global COVID-19 Summit. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-global-covid-19-summit-ending-the-pandemic-and-building-back-better-to-prepare-for-the-next. Accessed 11-04-2023.
484. U.S. Food and Drug Administration. FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations. (2021). https://www.fda.gov/news-events/press-announcements/fda-authorizes-booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations. Accessed 11-04-2023.
485. Gholami F, Hamidi Farahani R, Karimi Rahjerdi A, et al. Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years. BMC Infect Dis. 2023;23(1):118. https://doi.org/10.1186/s12879-023-08079-1.
486. World Health Organization. Strategic Advisory Group of Experts on Immunization (SAGE) - October 2021. (2021). https://www.who.int/news-room/events/detail/2021/10/04/default-calendar/sage_meeting_october_2021. Accessed 11-04-2023.
487. World Health Organization. WHO Director-General's remarks at the meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization - 4 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-meeting-of-the-strategic-advisory-group-of-experts-sage-on-immunization-4-october-2021. Accessed 11-04-2023.
488. World Health Organization. WHO Director-General's opening remarks on WHO recommendation for wider use of the RTS,S malaria vaccine. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-on-who-recommendation-for-wider-use-of-the-rts-s-malaria-vaccine. Accessed 11-04-2023.
489. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 7 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---7-october-2021. Accessed 11-04-2023.
490. Li L, Honda-Okubo Y, Baldwin J, Bowen R, Bielefeldt-Ohmann H, Petrovsky N. Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters. Vaccine. 2022;40(23):3182-92. https://doi.org/10.1016/j.vaccine.2022.04.041.
491. Islamic Republic of Iran (Canberra). COV-Iran Barekat & SpikoGen COVID-19 Vaccines. (2021). https://australia.mfa.gov.ir/en/newsview/668907/COV-Iran-Barekat-SpikoGen-COVID-19-Vaccines. Accessed 11-04-2023.
492. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 13 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---13-october-2021. Accessed 11-04-2023.
493. World Health Organization. WHO Director-General's opening remarks at the launch of the WHO-Qatar partnership “Healthy 2022 World Cup – Creating Legacy for Sport and Health”. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-launch-of-the-who-qatar-partnership-healthy-2022-world-cup-creating-legacy-for-sport-and-health. Accessed 11-04-2023.
494. World Health Organization. Director-General's speech on building health systems resilience during COVID-19 and beyond. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-speech-on-building-health-systems-resilience-during-covid-19-and-beyond. Accessed 11-04-2023.
495. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 21 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---21-october-2021. Accessed 11-04-2023.
496. World Health Organization. WHO Director-General's opening remarks at the 9th meeting of the IHR Emergency Committee on COVID-19 – 22 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-9th-meeting-of-the-ihr-emergency-committee-on-covid-19-22-october-2021. Accessed 11-04-2023.
497. World Health Organization. WHO Director-General's address at the World Health Summit. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-address-at-the-world-health-summit. Accessed 11-04-2023.
498. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 28 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---28-october-2021. Accessed 11-04-2023.
499. U.S. Food and Drug Administration. FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age. (2021). https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age. Accessed 11-04-2023.
500. World Health Organization. WHO Director-General's remarks at Session 1- Global Economy and Global Health at the G20 Summit - 30 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-session-1--global-economy-and-global-health-at-the-g20-summit. Accessed 11-04-2023.
501. World Health Organization. WHO Director-General's remarks at Session 3 - Sustainable Development at the G20 Summit - 31 October 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-session-3---sustainable-development-at-the-g20-summit---31-october-2021. Accessed 11-04-2023.
502. World Health Organization. WHO Director-General's remarks at the Member States Working Group on Strengthening WHO Preparedness - 3 November 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-member-states-working-group-on-strengthening-who-preparedness---3-november-2021. Accessed 11-04-2023.
503. World Health Organization. WHO issues emergency use listing for eighth COVID-19 vaccine. (2021). https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine. Accessed 11-04-2023.
504. World Health Organization. Director-General's opening remarks at Member States Information Session on COVID-19 - 4 November 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-member-states-information-session-on-covid-19---4-november-2021. Accessed 11-04-2023.
505. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 4 November 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---4-november-2021. Accessed 11-04-2023.
506. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 12 November 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---12-november-2021. Accessed 11-04-2023.
507. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Expands Eligibility for COVID-19 Vaccine Boosters. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters. Accessed 11-04-2023.
508. World Health Organization. WHO Director-General's opening remarks at the 2021 SADC seminar on TRIPS waiver - 23 November 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-2021-sadc-seminar-on-trips-waiver---23-november-2021. Accessed 11-04-2023.
509. World Health Organization. WHO Director-General's opening remarks at the First meeting of the WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO). (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-first-meeting-of-the-who-scientific-advisory-group-for-the-origins-of-novel-pathogens-(sago). Accessed 11-04-2023.
510. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 24 November 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---24-november-2021. Accessed 11-04-2023.
511. World Health Organization. Director-General's opening remarks at Member States Information Session on COVID-19 - 25 November 2021. (2021). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-member-states-information-session-on-covid-19---25-november-2021. Accessed 11-04-2023.
512. World Health Organization. WHO Director-General's opening remarks at the Special Session of the World Health Assembly - 29 November 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-special-session-of-the-world-health-assembly---29-november-2021. Accessed 11-04-2023.
513. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on the Omicron variant of SARS-CoV-2. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-the-omicron-variant-of-sars-cov-2. Accessed 11-04-2023.
514. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 1 December 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---1-december-2021. Accessed 11-04-2023.
515. U.S. Food and Drug Administration. FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns. (2021). https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19. Accessed 11-04-2023.
516. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 8 December 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---8-december-2021. Accessed 11-04-2023.
517. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure. Accessed 11-04-2023.
518. World Health Organization. WHO Director-General's opening remarks at the 8th meeting of the Access to COVID-19 Tools Accelerator Facilitation Council - 9 December 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-access-to-covid-19-tools-accelerator-facilitation-council---9-december-2021. Accessed 11-04-2023.
519. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17. Accessed 11-04-2023.
520. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 14 December 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---14-december-2021. Accessed 11-04-2023.
521. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 22 December 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---22-december-2021. Accessed 11-04-2023.
522. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19. Accessed 11-04-2023.
523. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. (2021). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain. Accessed 11-04-2023.
524. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 29 December 2021. (2021). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-press-conference---29-december-2021. Accessed 11-04-2023.
525. Stern A, Hamodia. Israel reports first case of 'Flurona'. (2021). https://hamodia.com/2021/12/30/israel-reports-first-case-of-flurona/. Accessed 11-04-2023.
526. The Times of Israel. ‘Flurona’: Israel records its first case of patient with COVID and flu at same time. (2021). https://www.timesofisrael.com/flurona-israel-records-its-first-case-of-patient-with-covid-and-flu-at-same-time/. Accessed 11-04-2023.
527. ABC News. Israel has reported a case of 'flurona' in a pregnant woman. What do we know about the double infection? (2021). https://www.abc.net.au/news/2022-01-04/israel-reports-first-case-flurona-coronavirus-flu/100737106. Accessed 11-04-2023.
528. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-multiple-actions-expand-use-pfizer-biontech-covid-19-vaccine. Accessed 12-04-2023.
529. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 6 January 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---6-january-2022. Accessed 12-04-2023.
530. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-shortens-interval-booster-dose-moderna-covid-19-vaccine-five-months. Accessed 12-04-2023.
531. World Health Organization. Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC). (2022). https://www.who.int/news/item/11-01-2022-interim-statement-on-covid-19-vaccines-in-the-context-of-the-circulation-of-the-omicron-sars-cov-2-variant-from-the-who-technical-advisory-group-on-covid-19-vaccine-composition. Accessed 12-04-2023.
532. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 12 January 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---12-january-2022. Accessed 12-04-2023.
533. World Health Organization. COVID-19 Case Management Webinar Series: COVID-19 and pregnancy. (2022). https://www.who.int/news-room/events/detail/2022/01/11/default-calendar/covid-19-case-management-webinar-series-covid-19-and-pregnancy. Accessed 12-04-2023.
534. World Health Organization. Director-General's opening remarks at the 10th meeting of the IHR Emergency Committee on COVID-19 - 13 January 2022. (2022). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-10th-meeting-of-the-ihr-emergency-committee-on-covid-19---13-january-2022. Accessed 12-04-2023.
535. World Health Organization. Director-General's introductory remarks at Member State Information Session on COVID-19 - 13 January 2022. (2022). https://www.who.int/director-general/speeches/detail/director-general-s-introductory-remarks-at-member-state-information-session-on-covid-19---13-january-2022. Accessed 12-04-2023.
536. World Health Organization. WHO recommends two new drugs to treat COVID-19. (2022). https://www.who.int/news/item/14-01-2022-who-recommends-two-new-drugs-to-treat-covid-19. Accessed 12-04-2023.
537. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 — 18 January 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-18-january-2022. Accessed 12-04-2023.
538. U.S. Food and Drug Administration. FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19. (2022). https://www.fda.gov/news-events/press-announcements/fda-takes-actions-expand-use-treatment-outpatients-mild-moderate-covid-19. Accessed 12-04-2023.
539. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-certain-monoclonal-antibodies-treat-covid-19-due-omicron. Accessed 12-04-2023.
540. World Health Organization. WHO Director-General's opening remarks at the 150th session of the Executive Board — 24 January 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-150th-session-of-the-executive-board-24-january-2022. Accessed 12-04-2023.
541. World Health Organization. WHO consultation on COVID vaccines research: Why do we need a pan-sarbecovirus vaccine? (2022). https://www.who.int/news-room/events/detail/2022/01/28/default-calendar/who-consultation-on-covid-vaccines-research-why-do-we-need-a-pan-sarbecovirus-vaccine. Accessed 12-04-2023.
542. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine. Accessed 12-04-2023.
543. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 1 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---1-february-2022. Accessed 12-04-2023.
544. World Health Organization. WHO Director-General's remarks at the ACT Accelerator Advocacy Event – 9 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-act-accelerator-advocacy-event-9-february-2022. Accessed 12-04-2023.
545. World Health Organization. WHO Director-General's remarks at mRNA Technology Transfer Hub – 11 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-mrna-technology-transfer-hub-11-february-2022. Accessed 12-04-2023.
546. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-monoclonal-antibody-treatment-covid-19-retains. Accessed 12-04-2023.
547. World Health Organization. WHO Director-General's remarks at the COVID-19 Global Action Meeting – 14 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-covid-19-global-action-meeting-14-february-2022. Accessed 12-04-2023.
548. World Health Organization. WHO Director-General's opening remarks at announcement “spokes” of mRNA technology transfer hub – 18 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-announcement-spokes-of-mrna-technology-transfer-hub-18-february-2022. Accessed 12-04-2023.
549. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 23 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-23-february-2022. Accessed 12-04-2023.
550. World Health Organization. WHO Director-General's opening remarks at first meeting of the Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response – 24 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-first-meeting-of-the-intergovernmental-negotiating-body-to-draft-and-negotiate-a-who-convention-agreement-or-other-international-instrument-on-pandemic-prevention-preparedness-and-response-24-february-2022. Accessed 12-04-2023.
551. World Health Organization. WHO Director-General's opening remarks at COVID-19 Global research & innovation forum – 24 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-covid-19-global-research-innovation-forum-24-february-2022. Accessed 12-04-2023.
552. World Health Organization. WHO Director-General's opening remarks at the 9th meeting of the Access to COVID-19 Tools Accelerator Facilitation Council - 28 February 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-9th-meeting-of-the-access-to-covid-19-tools-accelerator-facilitation-council---28-february-2022. Accessed 12-04-2023.
553. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 2 March 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-2-march-2022. Accessed 12-04-2023.
554. World Health Organization. WHO Director-General's keynote speech at the Global Pandemic Preparedness Summit. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-keynote-speech-at-the-global-pandemic-preparedness-summit. Accessed 12-04-2023.
555. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 and Ukraine – 9 March 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-and-ukraine-9-march-2022. Accessed 12-04-2023.
556. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on COVID-19 - 17 March 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-covid-19---17-march-2022. Accessed 12-04-2023.
557. World Health Organization. WHO Director-General's opening remarks at the WHO press conference – 23 March 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who-press-conference-23-march-2022. Accessed 12-04-2023.
558. U.S. Food and Drug Administration. FDA Roundup: March 25, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-march-25-2022. Accessed 12-04-2023.
559. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19-vaccines-older-and. Accessed 12-04-2023.
560. World Health Organization. WHO Director-General's opening remarks at the WHO press conference – 30 March 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who-press-conference-30-march-2022. Accessed 12-04-2023.
561. U.S. Food and Drug Administration. FDA Roundup: April 5, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-april-5-2022. Accessed 12-04-2023.
562. World Health Organization. WHO Director-General's opening remarks at the 11th meeting of the Emergency Committee for COVID-19 – 11 April 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-11th-meeting-of-the-emergency-committee-for-covid-19---11-april-2022. Accessed 12-04-2023.
563. World Health Organization. WHO Director-General's opening remarks at the Public Hearing regarding a new international instrument on pandemic preparedness and response – 12 April 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-public-hearing-regarding-a-new-international-instrument-on-pandemic-preparedness-and-response---12-april-2022. Accessed 12-04-2023.
564. World Health Organization. WHO Director-General's opening remarks at the WHO press conference – 13 April 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who-press-conference-13-April-2022. Accessed 12-04-2023.
565. U.S. Food and Drug Administration. FDA Roundup: April 15, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-april-15-2022. Accessed 12-04-2023.
566. World Health Organization. WHO Director-General's opening remarks at the ground-breaking ceremony for the WHO Global Centre for Traditional Medicine – 19 April 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-ground-breaking-ceremony-for-the-who-global-centre-for-traditional-medicine---19-april-2022. Accessed 12-04-2023.
567. World Health Organization. WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator. (2022). https://www.who.int/news/item/22-04-2022-who-recommends-highly-successful-covid-19-therapy-and-calls-for-wide-geographical-distribution-and-transparency-from-originator. Accessed 12-04-2023.
568. World Health Organization. WHO Director-General's opening remarks at the WHO press conference – 26 April 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who-press-conference-26-April-2022. Accessed 12-04-2023.
569. World Health Organization. WHO Director-General's opening remarks at the 10th meeting of the Access to COVID-19 Tools Accelerator Facilitation Council - 26 April 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-10th-meeting-of-the-access-to-covid-19-tools-accelerator-facilitation-council---26-april-2022. Accessed 12-04-2023.
570. World Health Organization. WHO Director-General's opening remarks at the WHO press conference – 4 May 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who-press-conference-4-May-2022. Accessed 12-04-2023.
571. World Health Organization. WHO Director-General's opening remarks at the ninth meeting of the Working Group on Strengthening WHO Preparedness and Response to Health Emergencies – 4 May 2022. (2022). https://www.who.int/director-general/speeches/detail/WHO-Director-Generals-opening-remarks-at-the-ninth-meeting-of-the-Working-Group-on-Strengthening-WHO-Preparedness-and-Response-to-Health-Emergencies. Accessed 12-04-2023.
572. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individuals. Accessed 12-04-2023.
573. World Health Organization. WHO Director-General's opening remarks at the WHO press conference – 10 May 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who-press-conference-10-May-2022. Accessed 12-04-2023.
574. U.S. Food and Drug Administration. FDA Roundup: May 10, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-may-10-2022. Accessed 12-04-2023.
575. World Health Organization. WHO Director-General's live speech at 2nd Global COVID Summit – 12 May 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-live-speech-at-2-nd-global-covid-summit-12-May-2022. Accessed 12-04-2023.
576. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-available-without-prescription-also. Accessed 12-04-2023.
577. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 17 May 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--17-may-2022. Accessed 12-04-2023.
578. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-vaccine-booster-dose. Accessed 12-04-2023.
579. World Health Organization. Director-General's speech at the Joint Working Session, G7 Health and Finance Ministers: Strengthening Global Health Financing. (2022). https://www.who.int/director-general/speeches/detail/director-general-s-speech-at-the-joint-working-session--g7-health-and-finance-ministers--strengthening-global-health-financing. Accessed 12-04-2023.
580. World Health Organization. Director-General's opening remarks at the 151st session of the Executive Board. (2022). https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-151st-session-of-the-executive-board. Accessed 12-04-2023.
581. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 1 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--1-june-2022. Accessed 12-04-2023.
582. World Health Organization. WHO Director-General's opening remarks at Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), first in-person meeting – 1 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-scientific-advisory-group-for-the-origins-of-novel-pathogens-(sago)--first-in-person-meeting---1-june-2022. Accessed 12-04-2023.
583. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing – 8 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing---8-june-2022. Accessed 12-04-2023.
584. World Health Organization. Preliminary Report for the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO). 2022. p. 1-44.
585. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the--member-state-information-session-on-covid-19-and-other-issues. Accessed 12-04-2023.
586. U.S. Food and Drug Administration. FDA Roundup: June 14, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-june-14-2022. Accessed 12-04-2023.
587. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 14 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--14-june-2022. Accessed 12-04-2023.
588. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children. Accessed 12-04-2023.
589. World Health Organization. WHO Director-General's remarks at G20 Health Ministers Meeting – 20 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-g20-health-ministers-meeting---20-june-2022. Accessed 12-04-2023.
590. World Health Organization. WHO Director-General's Opening Remarks at Vaccine Equity for Africa First Groundbreaking BioNTech SE - 23 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-generals-opening-remarks-at-vaccine-equity-for-africa-23-june-2022. Accessed 12-04-2023.
591. World Health Organization. WHO Director-General's opening remarks at International Health Regulations (2005) Emergency Committee regarding the multi-country monkeypox outbreak – 23 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-international-health-regulations-(2005)-emergency-committee-regarding-the-multi-country-monkeypox-outbreak---23-june-2022. Accessed 12-04-2023.
592. World Health Organization. WHO Director-General's statement on the report of the Meeting of the International Health Regulations (2005) Emergency Committee regarding the multi-country monkeypox outbreak. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-report-of-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee--regarding-the-multi-country-monkeypox-outbreak. Accessed 12-04-2023.
593. World Health Organization. WHO Director-General's remarks at G7 Leaders Summit – 27 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-g7-leaders-summit---27-june-2022. Accessed 12-04-2023.
594. World Health Organization. WHO Director-General's opening remarks at the media briefing – 29 June 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---29-june-2022. Accessed 12-04-2023.
595. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-recommends-inclusion-omicron-ba45-component-covid-19-vaccine-booster. Accessed 12-04-2023.
596. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing – 6 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing---6-july2022. Accessed 12-04-2023.
597. World Health Organization. WHO Director-General's opening remarks at 11th ACT-A Facilitation Council - 6 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-11th-act-a-facilitation-council---6-july-2022. Accessed 12-04-2023.
598. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pharmacists-prescribe-paxlovid-certain-limitations. Accessed 12-04-2023.
599. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-covid-19-and-other-issues. Accessed 12-04-2023.
600. U.S. Food and Drug Administration. FDA Roundup: July 8, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-july-8-2022. Accessed 12-04-2023.
601. World Health Organization. WHO Director-General's opening remarks at Ground-breaking of the WHO Regional Emergency Hub – 9 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-ground-breaking-of-the-who-regional-emergency-hub---9-july-2022. Accessed 12-04-2023.
602. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 12 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--12-july-2022. Accessed 12-04-2023.
603. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted. Accessed 12-04-2023.
604. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 20 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--20-july-2022. Accessed 12-04-2023.
605. World Health Organization. WHO Director-General's opening remarks at second meeting of the IHR Emergency Committee regarding the multi-country outbreak of monkeypox – 21 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-second-meeting-of-the-ihr-emergency-committee-regarding-the-multi-country-outbreak-of-monkeypox---21-july-2022. Accessed 12-04-2023.
606. World Health Organization. WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues - 21 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-member-state-information-session-on-covid-19-and-other-issues---21-july-2022. Accessed 12-04-2023.
607. World Health Organization. WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox - 23 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022. Accessed 12-04-2023.
608. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 27 July 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--27-july-2022. Accessed 12-04-2023.
609. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing – 17 August 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--17-august-2022. Accessed 12-04-2023.
610. U.S. Food and Drug Administration. FDA Roundup: August 19, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-august-19-2022. Accessed 12-04-2023.
611. World Health Organization. WHO Director-General's opening remarks at the COVID-19 media briefing– 25 August 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing--25-august-2022. Accessed 12-04-2023.
612. World Health Organization. WHO Director-General's opening remarks at media briefing – 31 August 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-media-briefing---31-august-2022. Accessed 12-04-2023.
613. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use. Accessed 12-04-2023.
614. World Health Organization. WHO Director-General's opening remarks at Member State Information Session on COVID-19 and other issues. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-state-information-session-on-covid-19-and-other-issues. Accessed 12-04-2023.
615. World Health Organization. WHO Director-General's remarks at the Monkeypox Outbreak: virtual dialogue between affected communities and WHO leadership Geneva, Switzerland – 2 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-at-the-Monkeypox-Outbreak-virtual-dialogue-between-affected-communities-and-WHO-leadership-Geneva-Switzerland-2-September-2022. Accessed 12-04-2023.
616. World Health Organization. WHO Director-General's opening remarks at the media briefing– 7 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing--7-september-2022. Accessed 12-04-2023.
617. World Health Organization. WHO Director-General's opening remarks at the media briefing– 14 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing--14-september-2022. Accessed 12-04-2023.
618. Sachs JD, Abdool Karim S, Aknin L, et al. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly. The Lancet. 2020;396(10257):1102-24. https://doi.org/10.1016/S0140-6736(20)31927-9.
619. World Health Organization. WHO Director-General's opening remarks at the launch of The Lancet COVID-19 Commission Final Report – 15 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-launch-of-the-lancet-covid-19-commission-final-report---15-september-2022. Accessed 12-04-2023.
620. Sullivan K, Gumbrecht J, Malloy A, Liptak K, CNN. Biden: ‘The pandemic is over’. (2022). https://edition.cnn.com/2022/09/18/politics/biden-pandemic-60-minutes/index.html. Accessed 12-04-2023.
621. World Health Organization. WHO Director-General's opening remarks at the media briefing– 22 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing--22-september-2022. Accessed 12-04-2023.
622. World Health Organization. WHO Director-General's opening remarks at the UNGA UNSG-hosted event: “Ending the pandemic through equitable access to COVID-19 vaccines, tests and treatments” – 23 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-unga-unsg-hosted-event---ending-the-pandemic-through-equitable-access-to-covid-19-vaccines--tests-and-treatments----23-september-2022. Accessed 12-04-2023.
623. World Health Organization. WHO Director-General's opening remarks at the Global Preparedness Monitoring Board (GPMB) Board Meeting Hosted/organised by: GPMB Secretariat - 30 September 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-global-preparedness-monitoring-board-(gpmb)-board-meetinghosted-organised-by--gpmb-secretariat---30-september-2022. Accessed 12-04-2023.
624. World Health Organization. WHO Director-General's opening remarks at the media briefing – 5 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-5-october-2022. Accessed 12-04-2023.
625. World Health Organization. WHO Director-General's closing remarks at the meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization - 6 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-closing-remarks-at-the-meeting-of-the-strategic-advisory-group-of-experts-(sage)-on-immunization---6-october-2022. Accessed 12-04-2023.
626. U.S. Food and Drug Administration. FDA Roundup: October 7, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-october-7-2022. Accessed 12-04-2023.
627. World Health Organization. WHO Director-General's opening remarks at media briefing – 12 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-media-briefing---12-october-2022. Accessed 12-04-2023.
628. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines. Accessed 12-04-2023.
629. World Health Organization. WHO Director-General's opening remarks at the 13th meeting of the IHR Emergency Committee on COVID-19 pandemic – 13 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-13th-meeting-of-the-ihr-emergency-committee-on-covid-19-pandemic---13-october-2022. Accessed 12-04-2023.
630. World Health Organization. WHO Director-General's keynote speech at the Opening Ceremony of the World Health Summit - 16 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-keynote-speech-at-the-opening-ceremony-of-the-world-health-summit---16-october-2022. Accessed 12-04-2023.
631. U.S. Food and Drug Administration. FDA Roundup: October 18, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-october-18-2022. Accessed 12-04-2023.
632. World Health Organization. WHO Director-General's opening remarks at media briefing – 19 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-media-briefing---19-october-2022. Accessed 12-04-2023.
633. U.S. Food and Drug Administration. FDA Roundup: October 21, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-october-21-2022. Accessed 12-04-2023.
634. World Health Organization. WHO Director-General's opening remarks at 3rd meeting of the IHR Emergency Committee: multi-country outbreak of monkeypox - 20 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-3rd-meeting-of-the-ihr-emergency-committee--multi-country-outbreak-of-monkeypox---20-october-2022. Accessed 12-04-2023.
635. World Health Organization. WHO Director-General's remarks at the World Bio Summit 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-world-bio-summit-2022. Accessed 12-04-2023.
636. World Health Organization. WHO Director-General's opening remarks at Member State Information Session on COVID-19 and other issues – 27 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-27-october-2022. Accessed 12-04-2023.
637. World Health Organization. WHO Director-General's opening remarks at 12th ACT Accelerator Facilitation Council Meeting – 28 October 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-12th-act-accelerator-facilitation-council-meeting-28-october-2022. Accessed 12-04-2023.
638. World Health Organization. WHO Director-General's opening remarks at media briefing – 2 November 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-media-briefing---2-november-2022. Accessed 12-04-2023.
639. World Health Organization. WHO Director-General's remarks on the launch of a communiqué on the development of pharmaceuticals for global public health – 8 November 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-on-the-launch-of-a-communiqu-on-the-development-of-pharmaceuticals-for-global-public-health-8-november-2022. Accessed 12-04-2023.
640. World Health Organization. WHO Director-General's opening remarks at the media briefing – 9 November 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---9-november-2022. Accessed 12-04-2023.
641. World Health Organization. WHO Director-General's remarks at the Optimmunize Conference – 9 November 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-optimmunize-conference---9-november-2022. Accessed 12-04-2023.
642. World Health Organization. WHO Director-General's opening remarks at the launch of the Pandemic FundG20 Joint Finance Health Ministers Meeting - 13 November 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-launch-of-the-Pandemic-FundG20-Joint-Finance-Health-Ministers-Meeting-13-november-2022. Accessed 12-04-2023.
643. World Health Organization. WHO Director-General's opening remarks at the global health issues media briefing – 16 November 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-covid-19-media-briefing-16-november-2022. Accessed 12-04-2023.
644. World Health Organization. WHO Director-General's opening remarks at the media briefing – 2 December 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---2-december-2022. Accessed 12-04-2023.
645. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age. (2022). https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-updated-bivalent-covid-19-vaccines-children-down-6-months. Accessed 12-04-2023.
646. World Health Organization. WHO Director-General's opening remarks at the Standing Committee on Health Emergency Prevention, Preparedness and Response – 12 December 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-standing-committee-on-health-emergency-prevention--preparedness-and-response-12-december-2022. Accessed 12-04-2023.
647. World Health Organization. WHO Director-General's opening remarks at Member States Information Session on the Universal Health and Preparedness Review – 14 December 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-states-information-session-on-the-universal-health-and-preparedness-review---14-december-2022. Accessed 12-04-2023.
648. World Health Organization. WHO Director-General's opening remarks at the media briefing – 14 December 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---14-december-2022. Accessed 12-04-2023.
649. World Health Organization. WHO Director-General's opening remarks at the WHO, WIPO, WTO Joint Technical Symposium on the COVID-19 Pandemic: Response, preparedness, resilience - 16 December 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-who--wipo--wto-joint-technical-symposium-on-the-covid-19-pandemic--response--preparedness--resilience---16-december-2022. Accessed 12-04-2023.
650. World Health Organization. WHO Director-General's opening remarks at the media briefing – 21 December 2022. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---21-december-2022. Accessed 12-04-2023.
651. U.S. Food and Drug Administration. FDA Roundup: December 23, 2022. (2022). https://www.fda.gov/news-events/press-announcements/fda-roundup-december-23-2022. Accessed 12-04-2023.
652. World Health Organization. WHO Director-General's opening remarks at the media briefing – 4 January 2023. (2022). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---4-january-2023. Accessed 12-04-2023.
653. World Health Organization. WHO meets with Chinese officials on current COVID-19 situation. (2022). https://www.who.int/news/item/30-12-2022-who-meets-with-chinese-officials-on-current-covid-19-situation. Accessed 12-04-2023.